Company
About us
Acticor Team
Board of Directors
investors & Partners
Prizes & Awards
Our Product
Our product: Glenzocimab
GPVI / GLENZOCIMAB in brief
in acute ischemic stroke
⮑ Positive results actimis study
in other indications
Pipeline
About stroke
Key figures
What is a stroke?
Media
Press Releases
Publications
Media Coverage
Events
Investors
Welcome
Corporate Presentation
Share Overview
Shareholders' Meeting
Regulated Information
Financial Agenda
COntact
Investors
Press Releases
November 6, 2019
ACTICOR BIOTECH RAISES €7M IN ADDITION TO ITS SERIES B FINANCING, NOW COMPLETED AT €22,3M
